Clinical trials sponsored by Psoriasis Treatment Center of Central New Jersey

Phase breakdown

Conditions studied

Recruiting trials led by Psoriasis Treatment Center of Central New Jersey

• An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
  NCT03392337 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Duobrii in Combination With Biologics
  NCT04119102 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Dupixent and Narrowband UVB for Atopic Dermatitis
  NCT05285839 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
  NCT03827876 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
  NCT04347473 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Taltz in Combination With Enstilar for Psoriasis
  NCT04372277 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Psoriasis Treatment Center of Central New Jersey recruiting for?

Psoriasis Treatment Center of Central New Jersey is the lead sponsor of 6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.